OR WAIT null SECS
February 09, 2023
A multitude of conclusions surrounding distribution were reached at the Trade & Channels Strategies conference.
December 28, 2022
Observations from recent digital health events and a glimpse of what’s ahead—from Milan to Boca Raton
December 08, 2022
Companies along the pharma value chain strive for carbon neutrality
How artificial intelligence is improving the patient experience
October 27, 2022
Product commercialization in Canada is by no means simple, but the end result presents its advantages
October 07, 2022
Decision-making technologies come to the forefront of the AI space
How pharma can speed up the journey with direct-to-patient models
August 11, 2022
Pharma Commerce's podcasts offer new angles on its roster of key topics
August 10, 2022
Given the biopharma sector‘s complex set of networks and supply chains, so it is not straightforward to shift towards net zero across all operations.
July 05, 2022
Dr. Frank Doyle, Dean of the Paulson School of Engineering and Applied Sciences at Harvard University, outlines his recommendations for Fortune 500 c-suites as they strive to attract, develop, and retain the best talent for their upcoming 2023 strategic plans.